Try our beta test site
75 studies found for:    Open Studies | "Skin Neoplasms"
Show Display Options
Rank Status Study
21 Recruiting Laser Assisted Drug Delivery in the Treatment of Superficial Non Melanoma Skin Cancer: a Randomized Controlled Trial
Conditions: Bowen's Disease;   Superficial Basal Cell Carcinoma
Interventions: Device: full ablative CO2 laser;   Device: fractional ablative CO2 laser;   Drug: MAL;   Device: LED lamp;   Drug: lidocaine hydrochloride 2% with epinephrine
22 Recruiting XL888 + Vemurafenib + Cobimetinib for Unresectable BRAF Mutated Stage III/IV Melanoma
Conditions: Melanoma;   Skin Cancer
Interventions: Drug: XL888;   Drug: Vemurafenib;   Drug: Cobimetinib
23 Recruiting Combining PD-1 Blockade, CD137 Agonism and Adoptive Cell Therapy for Metastatic Melanoma
Conditions: Melanoma (Skin);   Skin Cancer
Interventions: Drug: Nivolumab;   Procedure: Surgery to Remove Tumor for Growth of TIL;   Drug: CD137;   Drug: Cyclophosphamide;   Drug: Fludarabine;   Biological: TIL Infusion;   Drug: Interleukin-2
24 Recruiting Phase I of Histone Deacetylase (HDAC) Inhibitor Panobinostat With Ipilimumab With Unresectable III/IV Melanoma
Conditions: Melanoma;   Skin Cancer
Interventions: Drug: Panobinostat;   Drug: Ipilimumab
25 Not yet recruiting Study of Cellular Adoptive Immunotherapy Using Autologous CD8+ Antigen-Specific T Cells and Anti-CTLA4 for Patients With Metastatic Uveal Melanoma
Condition: Melanoma and Other Malignant Neoplasms of Skin
Interventions: Biological: CD 8+ T Cells;   Drug: Cyclophosphamide;   Drug: Interleukin-2;   Drug: Ipilimumab
26 Recruiting Optical Tomographic Scanner for Skin Lesions
Condition: Skin Cancer, Benign Skin Tumor, Inflammatory Skin Disease
Intervention:
27 Not yet recruiting Talimogene Laherparepvec and Nivolumab in Treating Patients With Refractory Lymphomas or Advanced or Refractory Non-melanoma Skin Cancers
Conditions: Adenoid Cystic Carcinoma;   Adnexal Carcinoma;   Apocrine Carcinoma;   Eccrine Porocarcinoma;   Extraocular Cutaneous Sebaceous Carcinoma;   Hidradenocarcinoma;   Keratoacanthoma;   Malignant Sweat Gland Neoplasm;   Merkel Cell Carcinoma;   Microcystic Adnexal Carcinoma;   NK-Cell Lymphoma, Unclassifiable;   Non-Melanomatous Lesion;   Paget Disease;   Papillary Adenocarcinoma;   Primary Cutaneous Mucinous Carcinoma;   Refractory Anaplastic Large Cell Lymphoma;   Refractory Cutaneous T-Cell Non-Hodgkin Lymphoma;   Refractory Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma;   Refractory Mycosis Fungoides;   Refractory T-Cell Non-Hodgkin Lymphoma;   Sezary Syndrome;   Signet Ring Cell Carcinoma;   Skin Basal Cell Carcinoma;   Skin Basosquamous Cell Carcinoma;   Skin Squamous Cell Carcinoma;   Spiradenocarcinoma;   Squamous Cell Carcinoma of Unknown Primary Origin;   Stage III Skin Cancer;   Stage IV Skin Cancer;   Sweat Gland Carcinoma;   Trichilemmocarcinoma;   Vulvar Squamous Cell Carcinoma
Interventions: Other: Laboratory Biomarker Analysis;   Biological: Nivolumab;   Biological: Talimogene Laherparepvec
28 Recruiting Randomized Study of Nivolumab+Ipilimumab+/- SBRT for Metastatic Merkel Cell Carcinoma
Conditions: Merkel Cell Carcinoma;   Skin Cancer
Interventions: Drug: Nivolumab;   Drug: Ipilimumab;   Radiation: Stereotactic Body Radiation Therapy (SBRT)
29 Recruiting Tele-dermatology of Skin Cancer in a Cohort of Local Health Authority Employees in the Province of Bergamo
Conditions: Erysipelas;   Impetigo;   Herpes Zoster;   Molluscum Contagiosum;   Warts;   Tinea;   Melanoma;   Actinic Keratosis;   Basal Cell Carcinoma;   Squamous Cell Carcinoma
Interventions: Procedure: Screening;   Device: Tele-dermatology
30 Not yet recruiting Daylight Photodynamic Therapy for the Treatment of Actinic Keratoses in the Northeast United States
Conditions: Actinic Keratosis;   Non-melanoma Skin Cancer
Intervention: Drug: aminolevulinic acid HCl
31 Recruiting Study of Oral Azacitidine (CC-486) in Combination With Pembrolizumab (MK-3475) in Patients With Metastatic Melanoma
Conditions: Melanoma and Other Malignant Neoplasms of Skin;   Metastatic Melanoma
Interventions: Drug: Azacitidine;   Drug: Pembrolizumab
32 Recruiting A Study of the Efficacy and Safety of ASN-002 in Adult Patients With Low-risk Nodular Basal Cell Carcinoma
Conditions: Basal Cell Nevus Syndrome;   Skin Neoplasm;   Nodular Basal Cell Carcinoma of Skin
Interventions: Biological: ASN-002;   Drug: 5-FU
33 Not yet recruiting Study of Concurrent Intravenous and Intrathecal Nivolumab for Patients With Leptomeningeal Disease (LMD)
Conditions: Melanoma and Other Malignant Neoplasms of Skin;   Leptomeningeal Disease
Intervention: Drug: Nivolumab
34 Recruiting Phase II Study of Radiation Therapy and Vismodegib for Advanced Head/Neck Basal Cell Carcinoma
Conditions: Locally Advanced Basal Cell Carcinoma;   Skin Cancer;   Cutaneous Malignancy
Interventions: Drug: Vismodegib;   Radiation: Radiation therapy
35 Recruiting In Situ, Autologous Therapeutic Vaccination Against Solid Cancers With Intratumoral Hiltonol®
Conditions: Melanoma;   Head and Neck Cancer;   Sarcoma;   Non-Melanoma Skin Cancers
Intervention: Biological: Hiltonol
36 Not yet recruiting Treatment of Field Cancerization for Reduction in Tumor Burden - A Prospective Study
Conditions: Extensive Photodamage;   Actinic Keratosis;   History of Numerous Skin Cancers
Interventions: Device: Ultrapulse Carbon Dioxide Laser;   Device: Cellutome epidermal harvesting system
37 Not yet recruiting Negative Pressure Wound Therapy in Groin Dissection
Conditions: Neoplasm Metastasis;   Secondary Malignant Neoplasm of Lymph Node;   Non-healing Surgical Wound (Disorder);   Skin Neoplasms
Intervention: Device: PICO™
38 Recruiting Study of Skin Tumors in Tuberous Sclerosis
Conditions: Hereditary Neoplastic Syndrome;   Tuberous Sclerosis
Intervention:
39 Not yet recruiting Secured Access to Nivolumab for Adult Patients With Selected Rare Cancer Types
Conditions: Carcinoma, Renal Cell;   Head and Neck Neoplasm;   Skin Neoplasms;   Microsatellite Instability;   Penile Neoplasms
Intervention: Drug: Nivolumab
40 Recruiting Pembrolizumab in Patients With Locally Advanced or Metastatic Skin Cancer
Conditions: Recurrent Skin Carcinoma;   Skin Squamous Cell Carcinoma
Intervention: Biological: Pembrolizumab

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.